Just reported
From Iradimed's results release of October 30, 2026; its quarterly report has since been filed.
Actual
$24.2M
+14% y/y
+18% q/q
Guided
—
No guide given
Actual
$0.51
+19% y/y
+24% q/q
Guided
—
No guide given
Actual
$8.1M
+19% y/y
+27% q/q
Guided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The themes Iradimed is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
Shares of revenue are estimates for nine months ended September 30, 2026, not figures from a filing.
MRidium 3870 MRI-compatible IV infusion pump system
A pump system designed to deliver medicines and fluids in the MRI room. It includes a non-magnetic pump, mobile stand, disposable tubing, and optional remote controls.
MRidium 3860+ MRI-compatible IV infusion pump system
An earlier pump system for delivering medicines and fluids during MRI procedures. IRadimed planned to stop new system sales during 2026 while continuing contracted warranty and technical support.
3880 MRI-compatible patient vital signs monitoring system
A portable monitor that tracks measures such as heart activity, blood oxygen, blood pressure, breathing, and temperature during MRI procedures and patient transport.
3600 ferromagnetic detection system with remote alarm logging unit
Equipment that detects approaching ferromagnetic metal near an MRI room and gives staff a remote screen for viewing alarms and logging items.
MRidium disposable IV tubing sets
Single-use tubing sets that connect the infusion pump to a patient and are made for different types of fluid delivery.
IRadimed makes medical equipment that can operate in the powerful magnetic fields around MRI scanners. Its intravenous (IV) pumps deliver medicines and fluids during scans, while its monitors track patients’ vital signs; both are designed to move with patients between hospital departments and the scanner. It also sells equipment that detects ferromagnetic metal near MRI rooms, along with disposable tubing, maintenance agreements, and repair services.
Built from Iradimed Corp.’s own filings with the U.S. Securities and Exchange Commission (SEC). Figures are as reported, with per-share history restated onto today’s share basis. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.
$85.14-0.2%Nov 13 close
Figures through September 30, 2026, from the 10-Q filed October 30, 2026
IRadimed sells infusion pumps designed for use beside magnetic resonance imaging (MRI) scanners to hospitals, plus patient monitors and metal detectors.
Grade A+
The band under the price shows the grade on each date, built only from filings that were public by then.
Showing 2 of 41 quarters of Iradimed Corp.’s grade history. The other 39 go back to November 2016.